Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

Kidney International

Volumn 53, Issue 6, 1998, Pages 1696-1705

  Schwarz, Ute ^a   Amann, Kerstin ^a   Orth, Stephan R ^a   Simonaviciene, Aureliza ^a   Wessels, Sabine ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Albuminuria; Progressive renal disease; Renal growth; Renoprotective factor; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

ALCOHOL; CALCITRIOL; CYCLINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULOSCLEROSIS; KIDNEY MASS; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROTEINURIA; RAT; WEIGHT GAIN;

EID: 0031749608     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00951.x     Document Type: Conference Paper

References (54)

1. LIU SH, CHU HI: Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effect of dihydrotachysterol (A.T.10) and iron. (absract) Medicine (Baltimore) 22:103, 1943
2. CHRISTIANSEN C, RODBRO P, CHRISTIANSEN MS: Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet ii:700-703, 1978
3. 3 in the correction and prevention of renal osteodystrophy in patients with mild to moderate renal failure, in Vitamin D: A Chemical, Biochemical and Clinical Update, edited by NORMAN AW, SCHAEFER K, GRIGOLEIT HG, HERRATH DV, Berlin, Walter de Gruyter, 1985, pp 935-937
4. 3: Humoral and histomorphometric results. Miner Electrolyte Metabol 12:375-382, 1986
5. 3 administration in moderate renal failure. A prospective double blind trial. Kidney Int 35:661-669, 1989
6. NORDAL KP, DAHL E: Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab 5:929-936, 1988
7. RITZ E, KÜSTER S, SCHMIDT-GAYK H, STEIN G, SCHOLZ C, KRAATZ G, HEIDLAND A: Low-dose calcitriol prevents the rise in 1,84 iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant 10:2228-2234, 1995
8. 3 stimulates differentiation and 24-hydroxylase activity in cultured human keratinocytes, in Vitamin D: A Chemical, Biochemical and Clinical Update, edited by NORMAN AW, SCHAEFER K, GRIGOLEIT HG, HERRATH DV, Berlin, Walter de Gruyter, 1985, pp 935-937
9. 3 effects in primary cultures of growth cartilage of the rat. Calcif Tissue Int 49:340-348, 1991
10. REICHEL H, KOEFFLER P, NORMAN AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991, 1989
11. CUNNINGHAM D, GILCHRIST NL, COWAN RA, FORREST GJ, MCARDLE CS, SOUCOP M: Alfa calcitriol as a modulator of growth of low grade non-Hodgkin's lymphomas. Br Med J Clin Res Ed 291:1153-1155, 1985
12. DODD RC, COHEN MS, NEWMAN SL, GRAY TK: Vitamin D metabolites change the phenotype of monoblastic U 937 cells. Proc Nat Acad Sci USA 80:7538-7541, 1983
13. 3 on the growth of a renal carcinoma cell line. Kidney Int 29:834-840, 1986
14. 3 on compensatory renal growth in the growing rat. Kidney Int 40:212-218, 1991
15. 3 on human mesangial cells. Am J Kidney Dis 18:359-366, 199I
16. WEIH M, ORTH S, WEINREICH T, REICHEL T, RITZ E: Inhibition of growth by calcitriol in a proximal tubular cell line. Nephrol Dial Transplant 9:1390-1394, 1994
17. WEINREICH T, MÜLLER A, WÜTHRICH RP, BOOY C, BINSWANGER U: 1,25 dihydroxyvitamin D and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. Kidney Blood Press Res 19:325-331, 1996
18. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Develop 10:142-153, 1996
19. YOSHIDA Y, FOGO A, ICHIKAWA I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654-660, 1989
20. AMANN K, IRZYNIEC T, MALL G, RITZ E: The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: A stereological analysis. J Hypertens 11:969-975, 1993
21. WILDERMUTH S, DITTRICH K, SCHMIDT-GAYK H, ZAHN I, O'RIORDAN JL: Scintillation proximity assay for calcitriol in serum without high pressure liquid chromatography. Clin Chim Acta 220:61-70, 1993
22. MAGNOTTI RA, STEPHENS GW, ROGERS RK, PESCE AJ: Microplate measurement of urinary albumin and creatinine. Clin Chem 35:1371-1375, 1989
23. WEIBEL ER: Stereological methods, in Practical Methods for Biological Morphometry, London, Academic Press, 1979
24. WEIBEL ER: Stereological methods, in Theoretical Foundation (vol 2), London, Academic Press, 1979
25. QIAN SW, KONDAIH P, ROBERTS AB, SPORN MB: cDNA cloning by PCR of rat transforming growth factor beta-1. Nucl Acids Res 18:3059, 1990
26. EL NAHAS AM, BASSETT AH, COPE GH, LE CARPENTIER JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 40:29-34, 1991
27. VÉNIANT M, HEUDES D, CLOZEL JP, BRUNEVAL P, MÉNARD J: Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidnev Int 46:421-429, 1994
28. FLOEGE J, BURNS MW, ALPERS CE, YOSHIMURA A, PRITZL P, GORDON K, SEIFERT RA, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
29. PESCE CM, STRIKER LJ, PETEN E, ELLIOT SJ, STRIKER GE: Brief communication. Glomeruloselerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
30. KRIZ W: Progressive renal failure - Inability of podocytes to replicate and the consequences for development of glomerulosderosis. Nephrol Dial Transplant 11:1738-1742, 1996
31. FRIES JWU, SANDSTROM DJ, MEYER TW, RENNKE HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60:205-218, 1489
32. NAGATA M, SCHARER K, KRIZ W: Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney Int 42:136-147, 1994
33. AMANN K, NICHOLS C, TÖRNIG J, SCHWARZ U, ZEIER M, MALL G, RITZ E: Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Nephrol Dial Transplant 11:1003-1011, 1996
34. DWORKIN LD, FEINER HD, PARKER M, TOLBERT E: Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int 39:1112-1117, 1991
35. GRIFFIN KA, PICKEN M, BIDANI AK: Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model. Kidney Int 46:1010-1018, 1994
36. BIDANI AK, GRIFFIN KA, PICKEN M, LANSKY DM: Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol 265:F391-F398, 1993
37. GRETZ N, WALDHERR R, STRAUCH M: The remnant kidney model, in Experimental and Genetic Rat Models of Chronic Renal Failure, edited by GRETZ N, STRAUCH M, Basel, Karger, 1993, pp 1-28
38. STEFANSKI A, RITZ E, AMANN K: Factors affecting progression of renal failure - experimental data, in Nutritional Management of Renal Disease, edited by KOPPLE JD, MASSRY SG, Baltimore/Philadelphia/ Hong Kong/London/Munich/Sydney/Tokyo, Wiliams & Wilkins, 1997, pp 296-297
39. 3 in experimental renal hyperparathyroidism. Kidney Int 44:1259-1265, 1993
40. HSU CH, PATEL S, YOUNG E, SIMPSON RU: Production and metabolic clearance of calcitriol in acute renal failure. Kidney Int 33:530-535, 1988
41. SAWAYA BP, NICK J, KOSZEWSKI M, LANGUB C, MALLUCHE HH: A retinoid X receptor isoform is reduced in the remnant kidney of rats with mild renal failure. (abstract) J Am Soc Nephrol 7:2856, 1996
42. 3. Clin Exp Immunol 94:412-417, 1993
43. LILLEVANG ST, ROSENKVIST J, ANDERSEN CB, LARSEN S, KEMP E, KRISTENSEN T: Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat. Clin Exp Immunol 88:301-306, 1992
44. 3 suppresses human T helper inducer lymphocyte activity in vitro. J Immunol 134:3032-3035, 1985
45. 3 inhibits antigen induced T cell activation. J Immunol 133:1748-1754, 1984
46. 3. Immunol Lett 28:115-120, 1991
47. 3. J Cell Biochem 19:26-31, 1992
48. 3. Kidney Int 38(Suppl 29):9-16, 1990
49. 3, KH1060. Endocrinology 136:866-872, 1995
50. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103-1107, 1991
51. JOHNSSON C, TUFVESON G: MC 1288-A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts. Transplant Int 7:392-397, 1994
52. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 123:401-409, 1985
53. 3) induces TGF-beta 1 (TGF) synthesis in mouse proximal tubular cells (MCT) in vitro. (abstract) J Soc Nephrol 7:2097, 1996
54. KITAMURA M, SÜTÖ TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669-679, 1997